Mihir Taneja’s investing follows the same thesis as his building: take on what is structurally awkward or already written off, then build the capability to serve it properly.
Ashbury Capital acquires, licenses and sells pharmaceutical assets other operators have written off — recovering value from molecules whose commercial case was abandoned before their clinical one was.
In the index →Ajenat Holdings is the family office: a diversified holding company managing private capital across oil and gas, real estate, aircraft and sports entertainment.
In the index →KMR delivers solutions across pharmaceuticals, biotechnology and the medical sector, combining science, technology and commercialisation into a single approach.
In the index →The through-line is that none of these vehicles invest at arm’s length. Every one of them is run by someone who has built, scaled and sold in the same categories — eighteen companies, six of them acquired or sold to private equity. Diligence conducted by an operator asks different questions than diligence conducted by an allocator.
No fund sizes, return figures, or transaction values are published on this site.